Loading candles…
Kimia Biosciences Ltd, incorporated in 1993, is a public limited company operating in the pharmaceutical industry in India. It is involved in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and pharmaceutical products. The company focuses on various therapeutic areas including anti-diabetic, anticoagulant, antihistamine, and gastrointestinal agents. It maintains compliance with Good Manufacturing Practices (GMP) and has a dedicated manufacturing facility in Haryana equipped to handle complex chemical reactions. Kimia Biosciences holds a significant position in the generic API market within India.
This page is a live market overview for KIMIA BIOSCIENCES LIMITED (KIMIABL) on the BSE. As a listed security, KIMIA BIOSCIENCES LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for KIMIABL before placing trades on tick2trade.
As of the latest feed, KIMIABL last traded at ₹29.93 on BSE, down ₹0.43 (1.42%) from the previous close of ₹30.36. Today's session range is ₹28.15 – ₹30.42, against a 52-week band of ₹28.15 – ₹86.85. Traded volume today stands at 6.28K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for KIMIABL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether KIMIABL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for KIMIA BIOSCIENCES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in KIMIABL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated KIMIABL option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.